News Column

BRIEF: Dendreon stock plunges after warning

August 12, 2014

The Seattle Times

Aug. 12--Shares of Dendreon fell as much as 37 percent Tuesday after the struggling Seattle biotechnology company warned it might restructure its finances with "no guarantee that any such alternative will provide value for the company's stockholders."

The stock closed down 72 cents, or 34 percent, at $1.40 in regular trading.

Dendreon has $620 million in debt to repay by January 2016, and its quarterly 10-Q report filed Monday acknowledged for the first time a "significant risk" it will not be able to pay off or refinance that debt.


(c)2014 The Seattle Times

Visit The Seattle Times at

Distributed by MCT Information Services

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Seattle Times (WA)

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters